Paper21189227
Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation.
Chung EY and 7 others. J Nutr Biochem, 2011. Cited by 64 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. Papers, record 21189227. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21189227
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon-gamma | Major topic |
| Macrophages | Major topic |
| STAT1 Transcription Factor | Major topic |
| Stilbenes | Major topic |
| Animals | |
| Chemokine CXCL10 | |
| Down-Regulation | |
| Humans | |
| Janus Kinase 2 | |
| Mice | |
| Nitric Oxide | |
| Nitric Oxide Synthase | |
| Phosphorylation | |
| RNA, Messenger | |
| Resveratrol | |
| Transcription, Genetic |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,079,750 | Potential mechanisms of natural metabolites and botanical drugs foumulae for the treatment of non-alcoholic fatty liver disease: targeting the gut microbiota to modulate the immune system. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41079750 | PubMed |
| 40,076,963 | Resveratrol Upregulates Antioxidant Factors Expression and Downmodulates Interferon-Inducible Antiviral Factors in Aging. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076963 | PubMed |
| 38,001,807 | Resveratrol and Its Derivatives in Inflammatory Skin Disorders-Atopic Dermatitis and Psoriasis: A Review. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38001807 | PubMed |
| 37,242,501 | Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242501 | PubMed |
| 36,644,561 | Atherosclerosis severity in patients with familial hypercholesterolemia: The role of T and B lymphocytes. | Atheroscler Plus | 2022 | https://conductscience.org/library/papers/36644561 | PubMed |
| 35,440,885 | Hydroethanolic Extract of Grape Peel from Vitis labrusca Winemaking Waste: Antinociceptive and Anti-Inflammatory Activities. | Food Technol Biotechnol | 2022 | https://conductscience.org/library/papers/35440885 | PubMed |
| 35,252,158 | Traditional Chinese Medicine Compound-Loaded Materials in Bone Regeneration. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/35252158 | PubMed |
| 34,830,366 | Natural Compound Resveratrol Attenuates TNF-Alpha-Induced Vascular Dysfunction in Mice and Human Endothelial Cells: The Involvement of the NF-κB Signaling Pathway. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830366 | PubMed |
| 34,539,403 | Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34539403 | PubMed |
| 32,887,408 | Aronia melanocarpa Fruit Bioactive Fraction Attenuates LPS-Induced Inflammatory Response in Human Bronchial Epithelial Cells. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/32887408 | PubMed |
| 32,699,989 | The role of interferon-γ in cardiovascular disease: an update. | Inflamm Res | 2020 | https://conductscience.org/library/papers/32699989 | PubMed |
| 32,640,331 | Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. | Food Chem Toxicol | 2020 | https://conductscience.org/library/papers/32640331 | PubMed |
| 32,354,017 | A Biochemometric Approach for the Identification of In Vitro Anti-Inflammatory Constituents in Masterwort. | Biomolecules | 2020 | https://conductscience.org/library/papers/32354017 | PubMed |
| 31,913,856 | CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/31913856 | PubMed |
| 29,041,897 | Small molecule modulation of splicing factor expression is associated with rescue from cellular senescence. | BMC Cell Biol | 2017 | https://conductscience.org/library/papers/29041897 | PubMed |
| 27,726,306 | CXCL9: evidence and contradictions for its role in tumor progression. | Cancer Med | 2016 | https://conductscience.org/library/papers/27726306 | PubMed |
| 27,175,310 | Modulation of Inflammatory Response and Induction of Bone Formation Based on Combinatorial Effects of Resveratrol. | J Nanomed Nanotechnol | 2016 | https://conductscience.org/library/papers/27175310 | PubMed |
| 26,482,935 | Anti-inflammatory effects of vicenin-2 and scolymoside in vitro and in vivo. | Inflamm Res | 2015 | https://conductscience.org/library/papers/26482935 | PubMed |
| 25,725,784 | Overexpression of SIRT1 Induced by Resveratrol and Inhibitor of miR-204 Suppresses Activation and Proliferation of Microglia. | J Mol Neurosci | 2015 | https://conductscience.org/library/papers/25725784 | PubMed |
| 25,546,330 | The probiotic mixture VSL#3 dampens LPS-induced chemokine expression in human dendritic cells by inhibition of STAT-1 phosphorylation. | PLoS One | 2014 | https://conductscience.org/library/papers/25546330 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXCL10 | 3,627 | PubTator's text mining | https://conductscience.org/library/genes/3627 | NCBI Gene |
| CXCL9 | 4,283 | PubTator's text mining | https://conductscience.org/library/genes/4283 | NCBI Gene |
| IFNG | 3,458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| JAK2 | 3,717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
| NOS2 | 4,843 | PubTator's text mining | https://conductscience.org/library/genes/4843 | NCBI Gene |
| STAT1 | 6,772 | PubTator's text mining | https://conductscience.org/library/genes/6772 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21189227
GET https://conductscience.org/api/papers/v1/21189227/cited_by?page=2